(Q33366089)
Statements
1 reference
A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer (English)
1 reference
George Wilding
1 reference
Henry C Pitot
1 reference
Grace K Dy
1 reference
Alex A Adjei
1 reference
Lorelei J Hanson
1 reference
Charles Erlichman
1 reference
Steven R Alberts
1 reference
Scott H Kaufmann
1 reference
Laura Bruzek
1 reference
James P Thomas
1 reference
Sumithra Mandrekar
1 reference
Dona Alberti
1 reference
Kim Binger
1 reference
Rebecca Marnocha
1 reference
Kendra Tutsch
1 reference
1 May 2005
1 reference
1 reference
11
1 reference
3410-3416
1 reference
Identifiers
1 reference
1 reference